R1 gene therapy (Lorus)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameR1 gene therapy (Lorus)
Drug Alias Namecolon cancer gene therapy (Lorus)rAd5-R1
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionRibonucleotide reductase modulators
TargetsRibonucleotide reductase
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAptose Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAptose Biosciences Inc
Active IndicationsN/A
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A